A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

NCT04796896 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

11942

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2

Interventions

BIOLOGICAL: mRNA-1273
BIOLOGICAL: Placebo
BIOLOGICAL: mRNA-1273.214

Sponsor

ModernaTX, Inc.